Explore the reasons payers choose Eviti Connect:
In healthcare, the well-being of patients is goal number one. At NantHealth, we're committed to aligning the needs of payers and providers in pursuit of that goal—and Eviti Connect is leading the way.
As a payer, you are challenged to keep costs low while enabling appropriate care for your members. As healthcare costs skyrocket, how effectively are you managing your spending? If your answer leaves you thinking there has to be a better way, then take a look at Eviti Connect - a web-based application that electronically connects health plans and practices to verify treatments in real-time.
Eviti Connect validates decisions with evidence-based medicine and payer policies before treatment begins. The automated process reduces the administrative time involved in obtaining and providing authorizations, aligning all parties around value-based care.
Eliminate unwarranted variability in care through the application of nationally-accepted treatment standards at the moment of clinical prescribing, ensuring that compliance occurs at the front-end as opposed to back-end review after treatment has begun. You'll have confidence that your members are prescribed the most effective care at the most appropriate cost.
The Eviti oncology clinical library is the most comprehensive knowledgebase of evidence-based cancer treatments available. It easily enables identification of recommended evidence-based treatment options across the spectrum of cancer types, including individualized patient diagnosis, the details of drug and radiation treatment, the supportive drugs required for best reducing toxicities, the level of evidence based on the clinical trial study design and primary study endpoint, the expected outcomes and toxicities, and the estimated cost of treatment.
Clinical content is included in the library if it is both endorsed by one of the national oncology organizations and there is published clinical data to support the treatment. NantHealth reviews and considers recommendations, approvals, and guidelines from the US Food and Drug Administration [FDA], National Cancer Institute [NCI], National Comprehensive Cancer Network [NCCN] Compendium, American Society of Clinical Oncology [ASCO], American Society of Hematology [ASH], American Society for Therapeutic Radiology and Oncology [ASTRO], American College of Radiology [ACR] and other recognized professional societies for inclusion in the library.
Eviti Connect is an intelligent treatment validation platform using evidence-based medicine to give payers and providers confidence to prescribe and reimburse high-quality, high-value care.
The autoimmune diseases and drug therapies represented in the Eviti library account for the most commonly prescribed drugs (including biosimilars) and the most prevalent autoimmune conditions – such as inflammatory bowel disease, rheumatoid arthritis, plaque psoriasis, multiple sclerosis, and more. All drugs in the library are FDA approved for use with their respective conditions.
Eviti is an intelligent, evidence-based decision support and treatment validation platform that gives payers and providers confidence to prescribe and reimburse high-quality, high-value care. It streamlines authorization workflows and supports providers and payers from treatment plan prescription through validation and appeals.
Automatic electronic verification that treatments meet your plan's medical policy and plan language before the treatment is selected and ordered.
Identify off-pathway regimens per payer-specified parameters.
Enable value-based care by redirecting physicians to preferred treatment plans when appropriate, facilitating payer-preferred drug selection at the time of treatment plan entry.
Map patient demographic, diagnosis, treatment details and recommendations into health plan application, reducing errors and time associated with manual data entry.
There's a good chance that many providers in your network already use Eviti Connect to authorize treatments for other health plans, as over 7,700+ practices across the United States have registered to use Eviti Connect to submit treatment plans for authorization.
